Analyst Coverage
Print page
Email pageThe equity/research analysts at the firms listed below currently write research reports on Merrion Pharmaceuticals plc. Please note that this list is subject to change and that any estimates, forecasts or opinions are made by the analysts alone and do not represent the estimates, forecasts or opinions of Merrion. Merrion does not by its reference below imply its endorsement of or concurrence with such information, conclusions or recommendations. Reports issued may have become out of date after publication and should be read accordingly. Unless otherwise indicated, the research cannot be obtained from Merrion but investors may contact analyst directly in order to obtain copies of a research note.
Jack Gorman
Davy Stockbroker
www.davy.ie
| John Savin | |
| Edison Investment Research www.edisoninvestmentresearch.co.uk |
Investment Summary: Project Diversification Edison Research 28/02/2011 |
| Investment Summary: Switch to breast cancer Edison Research 19/11/2010 |
|
| Investment Summary: Imminent deals Edison Research 11/03/2010 |
|
| Investment Summary: Oral insulin goes clinical Edison Research 11/12/2009 |
|
| Investment Summary: Raising its profile Edison Research 05/11/2009 |
|
| Investment Summary: Nil by needle Edison Research 14/09/2009 |